- Live market news
- Stocks
- AVXL
Anavex Life Sciences Corp
AVXLStockUSA
Latest news on AVXLranked by Oyticker for market impact
- 25Impact
AVXL securities fraud class action lawsuit solicitation
A shareholder litigation firm is soliciting lead plaintiffs for a class action securities fraud lawsuit against Anavex Life Sciences. This is a legal notice, not a disclosure of new corporate facts or market-moving events.
AVXLBiotechnologyPharmaceuticals - 45Impact
AVXL Class Action Lawsuit Filed for Securities Law Violations
A class action lawsuit has been filed against Anavex Life Sciences Corp. (AVXL) alleging securities law violations. The suit's specific claims and timeline remain unclear from the available excerpt.
AVXLBiotechnologyPharmaceuticals - 55Impact
AVXL securities fraud lawsuit opportunity announced
Law firm SBS Law is soliciting lead plaintiffs for a securities fraud class action against Anavex Life Sciences (AVXL), indicating alleged misrepresentations or omissions by the company.
AVXLBiotechnologyPharmaceuticals - 25Impact
Legal Investigation Notice for GPGI, NUAI, PSIX, PRCT and Others
A law office has announced investigations into shareholder claims against multiple publicly traded companies across healthcare, energy, and industrial sectors. No specific allegations, damages, or corporate responses are detailed.
AVXLNUAIPRCTARDXGPGIPSIXHealthcareEnergyIndustrial Technology - 55Impact
AVXL securities fraud class action lawsuit solicitation
A shareholder litigation firm is soliciting lead plaintiffs for a class action securities fraud lawsuit against Anavex Life Sciences. This indicates prior disclosure failures or misstatements that triggered investor losses.
AVXLBiotechnologyPharmaceuticals - 55Impact
Securities class action filed against AVXL; alleged misstatements Nov 2025–Aug 2026
A class action lawsuit has been filed in U.S. District Court (S.D.N.Y.) against Anavex Life Sciences on behalf of shareholders who purchased securities during an approximately 9-month period ending August 28, 2026. The complaint alleges unspecified securities law violations.
AVXLBiotechnologyPharmaceuticals
What AVXL filed
- 3 Nov 2026
- 2 Nov 2026
- 20 Oct 2026
- 15 Oct 2026
- 28 Sept 2026
Shareholder vote results
- 9 Sept 2026
- 2 Sept 2026
- 28 Aug 2026
- 28 Aug 2026
- 28 Aug 2026
- 28 Aug 2026
- 25 Aug 2026
- 17 Aug 2026
- 11 Aug 2026
- 3 Aug 2026
From SEC EDGAR, the public record of what US-listed companies file. Each document opens on sec.gov.
Oyticker provides market information and analysis for educational purposes. It is not investment advice: you remain responsible for your own decisions.